Small Doses, Low Pressure with New Catheter
December 21, 2006
The FDA has granted 510(k) marketing clearance for Atrium Medical Corp.’s ClearWay RX, a therapeutic perfusion catheter indicated for localized delivery of therapeutic agents to the coronary and peripheral vasculature.
A low-pressure perfusion catheter that incorporates a patented microporous PTFE balloon, Clearway RX enables controlled infusion at very low pressures (2 - 4atm) for maximum local therapeutic effect at a discrete targeted location. Delivering a smaller quantity of a preferred therapeutic agent locally has been shown to help reduce systemic effects.
For more information visit www.atriummed.com